Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03090750Phase 1Completed
Phase 1, randomised, single-blind trial (3 arms), sponsored by Wake Forest University Health Sciences. Primary endpoint: Anxiety level of patients. Started Jul 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03090750.